NewsRx

Search our medical news database

Medical Device Business Week

Susan Hasty, Publisher

Table of Contents . . . April 7th, 2004

Non-Subscriber - Summaries Only

Related Areas: Other Issues in Medical Device Business Week | Other Publications

AVI BioPharma, Inc. - Neugene maker reports quarterly loss of $0.10 per share

Alfacell Corporation - Savadelis named chief financial officer at pharmaceutical firm

American Oriental Bioengineering - Bioengineering firm expects record revenue growth, income for 2003

Aspreva Pharmaceuticals Corp. - Autoimmune disease drug maker completes raises $57 million

Avitar, Inc. - Diagnostics company announces second closing of private placement

BioRexis Pharmaceutical Corp. - Biopharmaceutical firm completes $30M series B financing

Business & Finance - Scripps Research Institute plans Florida research hospital

Chronogen, Inc. - New management appointments named at drug discovery firm

Columbia Laboratories, Inc. - Women's health pharmaceutical firm reports loss of $0.20 per share

CombinatoRx, Inc. - Biopharmaceutical firm raises $30M in third venture capital round

Corixa Corp. - Immunotherapeutics firm reports quarterly loss of $0.31 per share

Cutting Edge Information - Pharmaceutical companies spend over $900M on cholesterol drugs, study shows

Cutting Edge Information - Report suggests solution to pharmaceutical industry productivity decline

Cypress Bioscience, Inc. - Biotech company approved for listing on Nasdaq

Cytogen Corporation - Oncology company reports record product revenues

Psychiatric Solutions, Inc. - Psychiatric Solutions reports 181% fourth quarter revenue increase

AEterna Laboratories, Inc. - Company expands pipeline to include obesity, oncology therapies

Acacia Research Corporation - $5.9M contract awarded for development of biowarfare technology

Academy of Allergy, Asthma and Immunology - Study: Inhaled steroid therapy does not reduce fetal growth

Agfa-Gevaert Group - Tips will help streamline cardiology workflow

Alexion Pharmaceuticals, Inc. - Pexelizumab mortality benefit reported from multiple trials

Allos Therapeutics, Inc. - Oncology company files shelf registration statement

Alnylam Pharmaceuticals, Inc. - Isis Pharmaceuticals enters RNAi alliance

Ambit Biosciences - Biosciences firm adds members to scientific advisory board

American Pharmaceutical Partners - NDA filed with FDA for nanoparticle-based Abraxane

Amgen, Inc. - FDA approves Sensipar for the treatment of secondary hyperparathyroidism

Anlyan Center for Medical Research & Education - Lactating mammary glands respond to changes in extracellular calcium levels

Annamalai University - Kinins may help mediate hypotensive effects of taurine

Array BioPharma, Inc. - ARRY-142886 cleared to advance into human clinical trials

Aspen Education Group - Therapeutic boarding schools opened for overweight, obese youths

AstraZeneca - Preoperative treatment with anastrozole reduces need for extensive surgery

AstraZeneca - STELLAR data presented at meeting

Aventis Bulk S.p.A. - Complete genome sequence of Saccharopolyspora erythraea reported

Avian Influenza - Chinese delegation visits Delaware to discuss avian influenza

Azienda Ospedaliera di Padova - Antiretroviral therapy does not prevent HPV-induced genital lesions

Bayer Pharmaceuticals Corporation - Avelox shows clinical success for acute exacerbations of chronic bronchitis

Baylor College of Medicine - Radiation effective for some prostate patients with recurrent cancer

Baylor College of Medicine - Tumor suppressor genes predict bladder cancer future

Biochema Schwaben - International Specialty Products acquires biocide maker

Biomira, Inc. - Phase II colorectal vaccine trial results updated

Boehringer Ingelheim - COPD outcomes study completes patient recruitment

Boehringer Ingelheim Pharmaceuticals, Inc. - Flomax improves chronic prostatitis/chronic pelvic pain syndrome symptoms

Bovine Spongiform Encephalopathy - Funding pending for Canadian cattle industry reeling from mad cow scare

Breast Cancer - Breast cancer foundation honors four leaders

Breast Cancer - MEP calls for European strategy in the fight against breast cancer

Breast Cancer - Older people lose out all around in breast cancer treatment and care

Breast Cancer - South African government criticized for funding arms but not screening programs

Breast Cancer - Study highlights importance of diet in disease prevention

Breast Cancer - Survival rates same for conservation treatment or mastectomy for recurrent DCIS

Breast Cancer - Younger survivors suffer more long-term after effects

Business & Finance - Berlin, Vermont, hospital re-submits expansion plan to state

Business & Finance - Deal withdrawn for North Carolina bankrupt hospital

Business & Finance - Vista Medical Technologies receives Nasdaq notification

Business Update - Health insurer president has $2.8 million compensation package

CHRU, Clermont-Ferrand - Downregulated BRCA1 in melanoma modifies its metastatic potential

CHU Rangueil - Real-time PCR can provide rapid, accurate diagnosis

CNRS-Ecole Normale Superieure de Lyon - Cell-penetrating, Rev-binding peptides can protect against HIV

California Institute of Technology - GyrB distinguishes members of Bacillus anthracis-cereus-thuringiensis group

California Pacific Medical Center - Impact of HCV coinfection on risk of HAART-induced liver damage reviewed

CardioTech International, Inc. - Alliance partners to accelerate development of drug-eluting stent

Case Western Reserve University - Nephrogenic fibrosing dermopathy linked to dysregulated matrix remodeling

Cedars Sinai Medical Center - Male carriers of germline mutations in BRCA2 are at increased risk for cancer

Cellomics, Inc. - New high content biology platform launched for basic science research

Celltech Americas - Study demonstrates Metadate CD has greater effect than Concerta

Celsion Corp. - Milestone payments received, first patients treated with Prolieve

Central Food Tech. Research Institute, Karnataka - Cleavage of precursor enzyme causes amylase secretion by Aspergillus

Chiba University - No link found between human G-protein beta 3 subunit variant and overweight

Cima Labs Inc. - Orally disintegrating drug receives FDA approval for schizophrenia

Columbia Laboratories, Inc. - UK approval granted for Striant SR

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook